Breast cancer (BC) is a heterogeneous disease that can be classified into estrogen receptorα-positive (ERα+) and HER2+ tumors as well astriple-negative (TN) tumors, which do not express high levels of these or the progesterone receptors(Prat & Perou, 2011). This evidence concerns the gene ERBB2 and breast cancer.